Hemiplegia Following Ischemic Stroke Clinical Trial
— REBUILTOfficial title:
China National Clinical Research Center for Neurological Diseases
NCT number | NCT04387474 |
Other study ID # | KY2019-089-02 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 10, 2020 |
Est. completion date | May 31, 2022 |
Verified date | February 2024 |
Source | Beijing Tiantan Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the effectiveness and safety of rehabilitation training based on brain-computer interface in improving the upper motor function, self-care ability in daily life and quality of life in patients with ischemic stroke. This study adopts centralized uniform random 1:1 grouping, subjects will be randomly assigned to the experimental group and the control group. Randomization schemes are generated by statistical professionals using SAS software.
Status | Completed |
Enrollment | 300 |
Est. completion date | May 31, 2022 |
Est. primary completion date | April 20, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Adult subjects (18 years<male or female=80 years ) 2. Ischemic stroke diagnosed by MRI within 1 month before randomization 3. Unilateral upper limb dysfunction with NIHSS score 1-3 at the time of randomization 4. Informed consent signed Exclusion Criteria: 1. Unable to understand or cooperate because of severe aphasia or cognitive impairment (CDR >0.5) or mental illness 2. A history of epilepsy 3. Sensory disorders or hallucinations 4. Internal carotid artery dissection or thrombolysis 5. Apraxia 6. Agnosia 7. Other diseases that may interfere with motor function 8. Severe cardiopulmonary disease, severe illness, and unstable vital signs 9. Severe balance dysfunction 10. Participating in other clinical trial 11. During pregnancy and lactation 12. The Numerical Rating Scale (NRS) scores of upper extremities>4. |
Country | Name | City | State |
---|---|---|---|
China | China National Clinical Research Center for Neurological Diseases | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Tiantan Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The changes of brain network properties. | Evaluated by fMRI before and after rehabilitaion. | 1 month and 3 months after randomization. | |
Primary | The improvement of upper limb motor function at 1 month after randomization. | Tested by Fugl-Meyer Assessment (FMA) scale. | 1 month after randomization compared with traditional rehabilitation strategy. | |
Secondary | The improvement of upper limb motor function at 3 month after randomization. | Tested by Fugl-Meyer Assessment (FMA) scale. | 3 months after randomization compared with traditional rehabilitation strategy . | |
Secondary | The improvement of upper limb motor function at 1, 3 month after randomization. | Tested by Action Research Arm Test (ARAT), The Wolf Motor Function Test (WMFT). | 1, 3 months after randomization compared with traditional rehabilitation strategy. | |
Secondary | The improvement in muscle tone at 1, 3 month after randomization. | Tested by the Modified Ashworth scale (MAS). | 1, 3 months after randomization compared with traditional rehabilitation strategy. | |
Secondary | The improvement of patients' ability to take care of themselves in daily life | Tested by Instrumental Activity of Daily living (IDAL). | 1, 3 months after randomization compared with traditional rehabilitation strategy. |